OPT logo

Opthea Limited (OPT) Company Overview

Profile

Full Name:

Opthea Limited

Sector:

Healthcare

Industry:

Biotechnology

Country:

Australia

IPO:

October 16, 2020

Indexes:

Not included

Website:

http://opthea.com

Description:

Opthea Limited is a biotechnology company focused on developing innovative treatments for eye diseases, particularly wet age-related macular degeneration. The company aims to improve vision and quality of life for patients through advanced therapies and clinical research.

Key Details

Price

$4.46

Market Cap

$686.34 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$124.70 K(+15.04% YoY)

Annual EPS

-$2.76(-7.17% YoY)

PE Ratio

-

Annual ROE

290.52%

Annual Debt To Equity

-1.87

Beta

1.00

Events Calendar

Earnings

Next earnings date:

Aug 29, 2025

Recent quarterly earnings:

Aug 30, 2024

Recent annual earnings:

Aug 30, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Oct 16, 2020

Analyst ratings

Recent major analysts updates

Jan 29, 25 HC Wainwright & Co.
Buy
Sep 3, 24 HC Wainwright & Co.
Buy
Sep 13, 23 Oppenheimer
Outperform
Aug 1, 23 HC Wainwright & Co.
Buy
May 16, 23 EF Hutton
Buy
Apr 17, 23 EF Hutton
Buy
Mar 13, 23 Oppenheimer
Outperform
Feb 24, 23 HC Wainwright & Co.
Buy
Dec 8, 22 HC Wainwright & Co.
Buy
Sep 16, 22 Citigroup
Buy

Screeners with OPT included

Growing Shares Outstanding
Most recommended stocks
Best performing stocks last 3 months
Stocks above SMA 50
Stocks below analysts price target
Healthcare sector
All stocks
Biotechnology industry
Small cap stocks
Stocks above SMA 200

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$4.46
OPT price is $4.46

Price All-time High

$13.50
OPT price is currently -66.96% below its historical high of $13.50

Price Analysts Target

$12.00
OPT price is currently -62.83% lower than the consensus analysts' forecast

Price Most Recent Change

-4.09%
OPT price was down -4.09% on Feb 28, 2025

Price YTD Change

+17.37%
OPT price is up +17.37% since January 1st

Price 3-Year Change

-21.06%
OPT price is down -21.06% over the past 3 years

Market cap

Market Cap

$686.34 M
OPT market capitalization is $686.34 million

Market Cap 3-Year Change

+139.75%
OPT market capitalization is up +139.75% over the past 3 years

Market Cap All-time High

$911.01 M
OPT market capitalization is currently -24.66% below its historical high of $911.01 million

Market Cap Sector Rank

71.41%
OPT market capitalization is higher than 71.41% of companies in Healthcare sector

Technical

Beta

1.00
OPT beta is 1.00

200-day SMA

$3.48
OPT price is currently +28.01% above its 200-day simple moving average

14-day RSI

41.04
OPT 14-day relative strength index is 41.04

30-day Relative Volume

1.32
OPT 30-day relative volume is 1.32

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$124.70 K
OPT annual revenue is $124.70 thousand

Annual Revenue Analysts Estimate

$9.95 M
OPT annual revenue is currently -98.75% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+15.04%
OPT annual revenue is up +15.04% year-on-year

Annual Revenue Sector Rank

5.2%
OPT annual revenue is higher than 5.2% of companies in Healthcare sector

Profit

Annual Gross Profit

-
OPT annual gross profit value is unknown

Annual Gross Margin

-
OPT annual gross profit margin value is unknown

Annual Operating Profit

-$191.84 M
OPT annual operating income is -$191.84 million

Annual Operating Margin

-153.89 K%
OPT annual operating profit margin is -153.89 thousand%

Annual Net Income

-$220.24 M
OPT annual net profit is -$220.24 million

Annual Net Margin

-176.67 K%
OPT annual net profit margin is -176.67 thousand%

EPS

Annual EPS

-$2.76
OPT annual earnings per share is -$2.76

Annual EPS Analysts Estimate

-$0.33
OPT annual earnings per share is currently +746.09% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

-7.17%
OPT annual earnings per share is down -7.17% year-on-year

Annual EPS Sector Rank

34.81%
OPT annual earnings per share is higher than 34.81% of companies in Healthcare sector

ROA & ROE

Annual ROA

-153.25%
OPT annual return on assets is -153.25%

Annual ROE

290.52%
OPT annual return on equity is 290.52%

EBIT & EBITDA

Annual EBIT

-$199.39 M
OPT annual earnings before interest & taxes is -$199.39 million

Annual EBITDA

-$199.29 M
OPT annual EBITDA is -$199.29 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
OPT price to earnings ratio value is unknown

PE Ratio Sector Rank

-
OPT price to earnings ratio is unknown

PB Ratio

PB Ratio

-9.05
OPT price to book ratio is -9.05

PB Ratio Sector Rank

2.89%
OPT price to book ratio is higher than 2.89% of companies in Healthcare sector

PS Ratio

PS Ratio

-
OPT price to sales ratio value is unknown

PS Ratio Sector Rank

-
OPT price to sales ratio is unknown

Enterprise value

Enterprise Value

$655.51 M
OPT enterprise value is $655.51 million

Enterprise Value Sector Rank

71.52%
OPT enterprise value is higher than 71.52% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
OPT EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
OPT EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

2.94
OPT annual current ratio is 2.94

Annual Quick Ratio

-
OPT annual quick ratio value is unknown

Leverage

Annual Debt To Equity

-1.87
OPT annual debt to equity ratio is -1.87

Annual Interest Coverage Ratio

-6.59
OPT annual interest coverage ratio is -6.59

Risk & Stability

Piotroski F-Score

-
OPT piotroski f-score value is unknown

Altman Z-Score

-5.44
OPT altman z-score is -5.44

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$188.79 M
OPT annual total assets is $188.79 million

Annual Non Current Assets

$598.70 K
OPT annual long term assets is $598.70 thousand

Annual Current Assets

$188.19 M
OPT annual total current assets is $188.19 million

Annual Cash & Cash Equivalents

$172.47 M
OPT annual cash & cash equivalents is $172.47 million

Equity

Annual Book Value

-$75.81 M
OPT annual book value is -$75.81 million

Annual Working Capital

$124.14 M
OPT annual working capital is $124.14 million

Liabilities

Annual Total Liabilities

$264.60 M
OPT annual total liabilities is $264.60 million

Annual Total Long Term Liabilities

$200.55 M
OPT annual total long term liabilities is $200.55 million

Annual Current Liabilities

$64.06 M
OPT annual total current liabilities is $64.06 million

Annual Accounts Payable

$38.06 M
OPT annual accounts payable is $38.06 million

Debt

Annual Total Debt

$141.65 M
OPT annual total debt is $141.65 million

Annual Total Debt 1-Year Change

+65.01%
OPT annual total debt is up +65.01% year-on-year

Annual Long Term Debt

$141.55 M
OPT annual long term debt is $141.55 million

Annual Short Term Debt

$93.00 K
OPT annual short term debt is $93.00 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$191.97 M
OPT annual total expenses is $191.97 million

Annual Operating Expenses

$191.97 M
OPT annual total operating expenses is $191.97 million

Annual Cost Of Goods Sold

-
OPT annual cost of goods sold value is unknown

Annual SGA

$15.49 M
OPT annual SGA is $15.49 million

Annual D&A

$103.00 K
OPT annual depreciation & amortization is $103.00 thousand

Annual Interest Expense

$30.26 M
OPT annual interest expense is $30.26 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$161.02 M
OPT annual cash flow from operations is -$161.02 million

Annual CFO 1-Year Change

-33.5%
OPT annual cash flow from operations is down -33.5% year-on-year

Annual CFI

-$33.50 K
OPT annual cash flow from investing activities is -$33.50 thousand

Annual CFI 1-Year Change

-52.27%
OPT annual cash flow from investing activities is down -52.27% year-on-year

Annual CFF

$243.73 M
OPT annual cash flow from financing activities is $243.73 million

Annual CFF 1-Year Change

+45.7%
OPT annual cash flow from financing activities is up +45.7% year-on-year

Free CashFlow

Annual FCF

-$161.05 M
OPT annual free cash flow is -$161.05 million

Annual FCF 1-Year Change

-33.51%
OPT annual free cash flow is down -33.51% year-on-year

CAPEX

Annual CAPEX

$33.50 K
OPT annual capital expenditures is $33.50 thousand

Annual CAPEX 1-Year Change

+52.27%
OPT annual capital expenditures is up +52.27% year-on-year

Institutional Ownership

Similar stocks

TLRY logo
Tilray Brands (TLRY)
IRMD logo
IRadimed (IRMD)
OFIX logo
Orthofix Medical (OFIX)
OnKure Therapeutics (OKUR)
CVAC logo
CureVac NV (CVAC)
AVNS logo
Avanos Medical (AVNS)
CeriBell (CBLL)
AVXL logo
Anavex Life Sciences (AVXL)
NUVB logo
Nuvation Bio (NUVB)

FAQ

  • What is the ticker symbol for Opthea Limited?
  • Does Opthea Limited pay dividends?
  • What sector is Opthea Limited in?
  • What industry is Opthea Limited in?
  • What country is Opthea Limited based in?
  • When did Opthea Limited go public?
  • Is Opthea Limited in the S&P 500?
  • Is Opthea Limited in the NASDAQ 100?
  • Is Opthea Limited in the Dow Jones?
  • When was Opthea Limited's last earnings report?
  • When does Opthea Limited report earnings?
  • Should I buy Opthea Limited stock now?

What is the ticker symbol for Opthea Limited?

The ticker symbol for Opthea Limited is NASDAQ:OPT

Does Opthea Limited pay dividends?

No, Opthea Limited does not pay dividends

What sector is Opthea Limited in?

Opthea Limited is in the Healthcare sector

What industry is Opthea Limited in?

Opthea Limited is in the Biotechnology industry

What country is Opthea Limited based in?

Opthea Limited is headquartered in Australia

When did Opthea Limited go public?

Opthea Limited's initial public offering (IPO) was on October 16, 2020

Is Opthea Limited in the S&P 500?

No, Opthea Limited is not included in the S&P 500 index

Is Opthea Limited in the NASDAQ 100?

No, Opthea Limited is not included in the NASDAQ 100 index

Is Opthea Limited in the Dow Jones?

No, Opthea Limited is not included in the Dow Jones index

When was Opthea Limited's last earnings report?

Opthea Limited's most recent earnings report was on Aug 30, 2024

When does Opthea Limited report earnings?

The next expected earnings date for Opthea Limited is Aug 29, 2025

Should I buy Opthea Limited stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions